Keyphrases
Radiotherapy
100%
Hypoxia
100%
Osteopontin
100%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
100%
Nasopharyngeal Carcinoma
46%
Head-and-neck Cancer
38%
Nasopharyngeal Carcinoma Cells
23%
CNE2
15%
Locoregional
15%
Cancer Patients
7%
ELISA Assay
7%
Supernatant
7%
Western Blotting
7%
MRNA Level
7%
Carcinoma
7%
Quantitative PCR
7%
Healthy Controls
7%
Poor Response
7%
Protein Level
7%
Cancer Cell Lines
7%
Significant Predictors
7%
Deoxygenation
7%
Multivariate Analysis
7%
Plasma Parameters
7%
Patient-controlled
7%
Treatment Outcome
7%
C666-1 Cells
7%
Tumor Hypoxia
7%
Complete Response Rate
7%
Tumor Treatment
7%
Normoxia
7%
Surrogate Marker
7%
Palliative Radiotherapy
7%
Biomarkers of Response
7%
Recurrent Nasopharyngeal Carcinoma
7%
Medicine and Dentistry
Nasopharynx Cancer
100%
Hypoxia
100%
Osteopontin
100%
Radiation Therapy
100%
Nasopharynx Carcinoma
61%
Head and Neck Cancer
30%
Nasopharyngeal Carcinoma Cell Line
15%
Enzyme Linked Immunosorbent Assay
15%
Messenger RNA
15%
In Vitro
7%
Biological Marker
7%
Carcinoma Cell
7%
Secretion (Process)
7%
Western Blot
7%
Carcinoma
7%
Multivariate Analysis
7%
Tumor Hypoxia
7%
Disease Marker
7%
Head and Neck Cancer Cell Line
7%
Reverse Transcription Polymerase Chain Reaction
7%
Pharmacology, Toxicology and Pharmaceutical Science
Hypoxia
100%
Nasopharynx Cancer
100%
Osteopontin
100%
Nasopharynx Carcinoma
76%
Head and Neck Cancer
38%
Enzyme-Linked Immunosorbent Assay
15%
Messenger RNA
15%
Western Blot
7%
Biological Marker
7%
Disease Marker
7%
Neoplasm
7%
Carcinoma
7%